Michael S. Perry net worth and biography

Michael Perry Biography and Net Worth

Appointed to the Board in February 2013, and as CEO in June 2017. Dr. Perry brings extensive experience across the global pharmaceutical/medical device value chain, including expertise in cell and cell-based gene therapies. He has been materially involved in the successful development and launch of over 30 prescription products, 14 of which achieved blockbuster status. He has held numerous past positions in the industry including Chief Scientific Officer of Novartis’ Cell & Gene Therapy Business Unit, Senior VP of business development and licensing for Novartis AG, Global Head of R&D for Baxter, and others. He is an independent Director on the board of Arrowhead Pharmaceuticals.

What is Michael S. Perry's net worth?: The estimated net worth of Michael S. Perry is at least $1.97 million as of November 21st, 2022. Dr. Perry owns 229,543 shares of AVITA Medical stock worth more than $1,967,184 as of April 25th. This net worth estimate does not reflect any other investments that Dr. Perry may own. Learn More about Michael S. Perry's net worth.
How do I contact Michael S. Perry?: The corporate mailing address for Dr. Perry and other AVITA Medical executives is 28159 Avenue Stanford Suite 220, Valencia CA, 91355. AVITA Medical can also be reached via phone at (833) 462-8482 and via email at [email protected]. Learn More on Michael S. Perry's contact information.
Has Michael S. Perry been buying or selling shares of AVITA Medical?: Michael S. Perry has not been actively trading shares of AVITA Medical during the last quarter. Learn More on Michael S. Perry's trading history.
Who are AVITA Medical's active insiders?: AVITA Medical's insider roster includes Suzanne Crowe (Director), and Michael Perry (CEO). Learn More on AVITA Medical's active insiders.
Are insiders buying or selling shares of AVITA Medical?: In the last year, AVITA Medical insiders bought shares 6 times. They purchased a total of 9,450 shares worth more than $147,997.50. In the last year, insiders at the sold shares 3 times. They sold a total of 8,156 shares worth more than $116,517.03. The most recent insider tranaction occured on December, 26th when CEO James Corbett sold 1,445 shares worth more than $19,204.05. Insiders at AVITA Medical own 2.0% of the company. Learn More about insider trades at AVITA Medical.
Information on this page was last updated on 12/26/2023.

Michael S. Perry Insider Trading History at AVITA Medical

Michael S. Perry Buying and Selling Activity at AVITA Medical

AVITA Medical Company Overview

AVITA Medical, Inc., together with its subsidiaries, operates as a regenerative medicine company in the United States and internationally. The company's lead product is the RECELL System, a cell harvesting device used for the treatment of thermal burn wounds, full-thickness skin defects, and repigmentation of stable depigmented vitiligo lesions. It develops RECELL GO to control the manual process of disaggregation, filtration, and soak time. The company was formerly known as AVITA Therapeutics, Inc. AVITA Medical, Inc. was incorporated in 2020 and is headquartered in Valencia, California.

Today's Range

Now: $8.57

$8.53

$9.27

50 Day Range

MA: $15.08

$8.55

$18.31

2 Week Range

Now: $8.57

$8.46

$21.70

Volume

149,342 shs

Average Volume

330,912 shs

Market Capitalization

$220.33 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.33

Global crypto currency reset (41 major banks signed up)

From Stansberry Research | Ad

Behind closed doors, at least 41 major US banks have signed up to a strange new crypto project...

Here's everything you need to know.